← Reddit

How does Anthropic actually measure over-refusal? (genuine question after watching their safety video)

Reddit · Personal_Count_8026 · May 8, 2026
A discussion examines an imbalance in AI safety testing, noting that while Anthropic's evaluations effectively identify genuinely harmful model outputs, they do not address over-refusal—instances where the model incorrectly declines legitimate requests from nurses, security professionals, and creative writers. The author argues that over-refusal is a more frequent failure mode than actual harmful outputs but receives less testing attention because it is harder to benchmark systematically.

Detailed Analysis

A recurring critique of large language model safety practices surfaces in community discussion around Anthropic's public-facing testing documentation: the persistent asymmetry between how under-refusal and over-refusal are measured, communicated, and prioritized. The post in question was prompted by an Anthropic video demonstrating red-team style evaluations designed to catch instances where Claude assists with genuinely harmful tasks. While acknowledging the validity of that work, the author raises a pointed concern — that the reverse failure mode, in which the model refuses or hedges on entirely legitimate requests, receives comparatively little formal scrutiny, public documentation, or dedicated measurement infrastructure. The practical examples cited are concrete and professionally recognizable: nurses seeking clinical information, security researchers studying exploits, fiction authors exploring dark themes, and parents seeking harm-reduction knowledge about drugs. Each represents a real-world use case where keyword pattern-matching heuristics, rather than genuine contextual reasoning, could produce a false positive refusal.

The structural critique embedded in the post is epistemological as much as it is about product quality. The author identifies a fundamental measurement asymmetry: harmful-output failures are discrete, documentable, and benchmarkable — a model either provided instructions for a dangerous act or it did not. Over-refusal failures, by contrast, are diffuse, contextual, and depend heavily on inferring user intent. A nurse who cannot get a medication threshold answered does not generate a headline; she simply closes the tab and loses trust in the tool. This makes over-refusal what economists might call an invisible cost — real and accumulating, but structurally harder to aggregate into the kind of evidence that drives organizational attention. The author's observation that the feedback mechanism for this failure mode is "a thumbs down button" is a pointed summary of how asymmetric the institutional response infrastructure currently is.

Anthropic has, in fact, addressed over-refusal in published materials, most notably in documentation surrounding Claude's character and in its model specification, which explicitly frames unhelpfulness as a non-trivial harm rather than a safe default. The company has acknowledged that refusing a reasonable request carries real costs — to the user, to trust in AI systems broadly, and to the argument that safety and helpfulness are complementary rather than opposed. Claude's constitutionification language around this is unusually direct for a major AI lab, framing an overly cautious model not as "safe" but as failing in a different dimension. Whether this philosophical framing translates into equally rigorous measurement practices, however, is precisely the gap the Reddit post is probing. Public-facing safety communications naturally emphasize the harms that are most legible and most reputationally consequential, which creates a presentation skew that does not necessarily reflect internal prioritization but can reasonably appear to from the outside.

The broader trend the post touches on is one of the defining tensions in applied AI safety work as language models move into professional and high-stakes domains. As Claude and similar systems are deployed in healthcare, legal, security, and educational contexts, the cost of false-positive refusals scales significantly — a model that cannot engage with clinical pharmacology is not useful to a clinician, regardless of its red-team performance. The field is increasingly grappling with the need for what some researchers call "dual-sided evals," evaluations that measure both harmful compliance and harmful over-restriction with equivalent rigor. The relative underdevelopment of the latter reflects both genuine methodological difficulty and the reputational asymmetry that shapes incentive structures: a model that helps with something dangerous generates immediate, visible scandal, while a model that frustrates ten thousand legitimate professionals generates a slow, invisible erosion of utility. Addressing this imbalance is likely to become a more prominent focus as deployment contexts deepen and the professional user base grows more vocal about friction costs.

Article image Read original article →